WHO ICTRP trial
EUCTR2015-001065-76-FR · ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)
EUCTR2015-001065-76-FR · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2015-001065-76-FR |
|---|---|
| Scientific title | N/A - ARCADE |
| Primary sponsor | ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP) |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): no Therapeutic confirmatory - (Phase III): yes Therapeutic use (Phase IV): no |
| Countries | France |
| Conditions | MedDRA version: 18.0 Level: PT Classification code 10014316 Term: Ehlers-Danlos syndrome System Organ Class: 10010331 - Congenital, familial and genetic disorders |
| Interventions | Trade Name: IRBESARTAN Product Name: IRBESARTAN Pharmaceutical Form: Coated tablet INN or Proposed INN: irbesartan Concentration unit: mg milligram(s) Concentration type: equal Concentration number: 150- Pharmaceutical form of the placebo… |
| Registration date | Aug 9, 2015 |
| Target size | 169 |
| Secondary IDs | P140918 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: